A PHASE 1 STUDY TO ESTIMATE THE RELATIVE BIOAVAILABILITY OF CO-ADMINISTERED FORMULATIONS OF AZITHROMYCIN MICROSPHERE AND CHLOROQUINE TEST FORMULATION COMPARED WITH CO-ADMINISTERED IMMEDIATE RELEASE INDIVIDUAL AZITHROMYCIN AND CHLOROQUINE TABLETS IN HEALTHY ADULT SUBJECTS: